artificial intelligence (ai) methodology in structural biology (AstraZeneca ltd)
90
Structured Review
AstraZeneca ltd
artificial intelligence (ai) methodology in structural biology
Artificial Intelligence (Ai) Methodology In Structural Biology, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/artificial+intelligence+methodologies/artificial+intelligence++ai++methodology+in+structural+biology/pm36804676-5-71-11
Average 90 stars, based on 1 article reviews
Artificial Intelligence (Ai) Methodology In Structural Biology, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/artificial+intelligence+methodologies/artificial+intelligence++ai++methodology+in+structural+biology/pm36804676-5-71-11
Average 90 stars, based on 1 article reviews
artificial intelligence (ai) methodology in structural biology - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Imaging:Article Title: Artificial intelligence for compound pharmacokinetics prediction. Article Snippet: Optimisation of compound pharmacokinetics (PK) is an integral part of drug discovery and development.. Animal in vivo PK data as well as human and animal in vitro systems are routinely utilised to evaluate PK in humans.. In recent years machine learning and artificial intelligence (AI) emerged as a major tool for modelling of in vivo animal and human PK, enabling prediction from chemical structure early in drug discovery, and therefore offering opportunities to guide the design and prioritisation of molecules based on relevant in vivo properties and, ultimately, predicting human PK at the point of design. |